[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:lennox-gastaut-syndrome":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":63,"states":64},"Lennox-Gastaut Syndrome",8,3,[8,16,22,28,36,43,50,56],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05066217","An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome",[12],"Phase 3","RECRUITING","2026-08-26T02:18:12.612955Z","2026-05-05T02:43:27.656169Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05219617","Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults",[12],"2026-08-26T02:15:34.659160Z","2026-05-05T02:35:31.641465Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT05374824","Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome",[],"2026-08-26T02:18:38.077159Z","2026-05-13T02:55:06.302644Z",{"nct_id":29,"title":30,"phases":31,"status":33,"updated_at":34,"content_modified":35},"NCT06738732","CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in with Dravet Syndrome And\u002For Lennox-Gastaut Syndrome",[32],"Phase 1\u002FPhase 2","NOT_YET_RECRUITING","2026-08-26T02:18:52.966503Z","2026-05-05T02:43:29.500665Z",{"nct_id":37,"title":38,"phases":39,"status":33,"updated_at":41,"content_modified":42},"NCT07728097","A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS",[40],"Phase 4","2026-08-26T02:17:30.145302Z","2026-07-30T01:46:14.448739Z",{"nct_id":44,"title":45,"phases":46,"status":47,"updated_at":48,"content_modified":49},"NCT07555171","EEG Dynamics in Lennox-Gastaut Syndrome Patients Undergoing Fenfluramine Treatment",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:24.970704Z","2026-06-16T05:54:07.888889Z",{"nct_id":51,"title":52,"phases":53,"status":47,"updated_at":54,"content_modified":55},"NCT06908226","A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)",[12],"2026-08-26T02:17:56.243868Z","2026-06-16T05:54:07.839709Z",{"nct_id":57,"title":58,"phases":59,"status":60,"updated_at":61,"content_modified":62},"NCT06719141","A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T02:13:13.379935Z","2026-05-05T02:43:27.835432Z",[],[65,69,72,75,78,81,84,87,90,93,96],{"state":66,"count":67,"slug":68},"California",4,"california",{"state":70,"count":67,"slug":71},"Florida","florida",{"state":73,"count":67,"slug":74},"Illinois","illinois",{"state":76,"count":67,"slug":77},"Minnesota","minnesota",{"state":79,"count":67,"slug":80},"New Jersey","new-jersey",{"state":82,"count":67,"slug":83},"New York","new-york",{"state":85,"count":67,"slug":86},"Texas","texas",{"state":88,"count":6,"slug":89},"Arkansas","arkansas",{"state":91,"count":6,"slug":92},"Idaho","idaho",{"state":94,"count":6,"slug":95},"Maryland","maryland",{"state":97,"count":6,"slug":98},"Massachusetts","massachusetts"]